ArticleNeuro-oncology2020

HER2 antibody-drug conjugate controls growth of breast cancer brain metastases in hematogenous xenograft models, with heterogeneous blood-tumor barrier penetration unlinked to a passive marker.

Brunilde Gril et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.